Mesenchymal stem cells with enhanced therapeutic properties. The present invention refers to a method for obtaining mesenchymal stem cells (MSCs) with enhanced immunosuppression, chondroprotection and chondrodifferentiation properties, and enhanced capability to promote the proliferation of chondrocytes. The method comprises contacting the MSCs; culturing MSC in a induction media supplemented with 0.01 to 100 µg/ml of an ATP-synthase inhibitor; and removing the induction media to obtain MSC with enhanced activity. Moreover, the present invention also refers to the MSCs themselves and to their use for cell therapy purposes, preferably for treating autoimmune and/or osteoarticular diseases.
Idioma originalInglés estadounidense
Número de patenteWO/2021/105926
Fecha de prioridad26/11/19
EstadoPresentada - 2019


Profundice en los temas de investigación de 'Mesenchymal Stem Cells with Enhanced Therapeutic Properties'. En conjunto forman una huella única.

Citar esto